Crinetics Pharmaceuticals In shares owned by UBS O'Connor
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crinetics Pharmaceuticals In by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.3M | 25k | 51.10 |
| 2024-03-31 | $282k | 6.0k | 46.81 |
| 2023-09-30 | $1.2M | 121k | 9.80 |
| 2023-06-30 | $1.0M | 56k | 18.02 |
| 2023-03-31 | $537k | 33k | 16.06 |
| 2022-12-31 | $2.1M | 112k | 18.30 |
| 2022-09-30 | $1.8M | 91k | 19.64 |
| 2022-06-30 | $1.6M | 88k | 18.65 |
| 2022-03-31 | $1.4M | 65k | 21.95 |